Thompson Siegel & Walmsley’s Cabot Corp CBT Stock Holding History

Thompson Siegel & Walmsley’s Portfolio CBT Stock Details CBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10	Closed	–	–	665
2019 Q4	$0	Buy	+10	New	+$464	﹤0.01%	798

Other funds holding CBT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Thompson Siegel & Walmsley's CBT Position: Q1 2020 in Review

Thompson Siegel & Walmsley sold out of Cabot Corp (CBT) in Q1 2020, closing a stake of 10 shares.

Thompson Siegel & Walmsley first reported a position in CBT in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 256 funds tracked by Wall St. Rank hold CBT as of Q1 2020.

Thompson Siegel & Walmsley reported no remaining Cabot Corp position as of Q1 2020 after selling out during the quarter.
Thompson Siegel & Walmsley sold 10 Cabot Corp shares in Q1 2020.
Thompson Siegel & Walmsley first reported a position in Cabot Corp in Q4 2019 and held it in 1 quarter.
Thompson Siegel & Walmsley's Cabot Corp position peaked at $0 in Q4 2019.
256 funds tracked by Wall St. Rank held Cabot Corp as of Q1 2020.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2020, filed 12 May 2020.